Floatz logo

6 assets in Acute Myelomonocytic Leukemia M4

Therapeutic assets addressing Acute Myelomonocytic Leukemia M4, rated under Floatz methodology v0.2 and sorted by current rating.

AssetSponsorPhaseRating
Cytarabine
Acute Myelomonocytic Leukemia M4
University of AlbertaP3BBB (78)
Daunomycin
Acute Myelomonocytic Leukemia M4
National Cancer Institute (NCI)P3BBB (77)
Azacitidine
Acute Myelomonocytic Leukemia M4
University of ChicagoP2BB (69)
Decitabine
Acute Myelomonocytic Leukemia M4
Roswell Park Cancer InstituteP3BB (66)
Gemtuzumab Ozogamicin
Acute Myelomonocytic Leukemia M4
National Cancer Institute (NCI)P2BB (64)
Cpx-351
Acute Myelomonocytic Leukemia M4
Case Comprehensive Cancer CenterP2NR ()